The influence of probiotics on the cervical malignancy diagnostics quality;Uticaj probiotika na kvalitet dijagnostike maligniteta cerviksa

Vojnosanitetski Pregled

Volumn 68, Issue 11, 2011, Pages 956-960

  Perišić, Živko ^a   Perišić, Nataša ^a   Kon, Svetlana Goločorbin ^b   Vešović, Dušan ^b   Jovanović, Ana Mitrović ^a   Mikov, Momir ^c  

^a UNIVERSITY OF BELGRADE   (Serbia)

^b UNIVERSITY OF NOVI SAD   (Serbia)

^c Belgrade's Medical Center   (Serbia)

Author keywords

Administration; Lactobacillus reuteri; Lactobacillus rhamnosus; Oral; Probiotics; Treatment outcome; Vaginal smears

Indexed keywords

ANTIINFECTIVE AGENT; LACTOGYN; PROBIOTIC AGENT; UNCLASSIFIED DRUG;

ARTICLE; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; FALSE NEGATIVE RESULT; FALSE POSITIVE RESULT; FEMALE; HUMAN; LACTOBACILLUS REUTERI; LACTOBACILLUS RHAMNOSUS; MAJOR CLINICAL STUDY; MICROBIOLOGICAL EXAMINATION; SQUAMOUS CELL; UTERINE CERVIX CYTOLOGY; VAGINA FLORA; VAGINITIS;

ADULT; CERVIX UTERI; FEMALE; HUMANS; PROBIOTICS; UTERINE CERVICAL NEOPLASMS; VAGINA; VAGINAL SMEARS; VAGINOSIS, BACTERIAL;

EID: 80955143352     PISSN: 00428450     EISSN: None     Source Type: Journal    
DOI: 10.2298/VSP100809001P     Document Type: Article

References (21)

1. Reid G. Safe and efficacious probiotics: what are they? Trends Microbiol. 2006; 14(8): 348-52.
2. Reid G, Bruce AW. Urogenital infections in women: can probiotics help? Postgrad Med J. 2003; 79(934): 428-32.
3. Reid G, Bruce AW. Probiotics to prevent urinary tract infections: the rationale and evidence. World J Urol. 2006; 24(1): 28-32.
4. Reid G. Probiotic Lactobacilli for urogenital health in women. J Clin Gastroenterol. 2008; 42 Suppl 3: Pt 2:S234-6.
5. Spiegel CA. Bacterial vaginosis. Clin Microbiol Rev. 1991; 4(4): 485-502.
6. Myziuk L, Romanowski B, Johnson SC. BVBlue test for diagnosis of bacterial vaginosis. J Clin Microbiol 2003; 41: 1925-1928.
7. Klebanoff MA, Schwebke JR, Zhang J, Nansel TR, Yu KF, Andrews WW. Vulvovaginal symptoms in women with bacterial vaginosis. Obstet Gynecol. 2004; 104(2): 267-72.
8. Morelli L, Zonenenschain D, Del Piano M, Cognein P. Utilization of the intestinal tract as a delivery system for urogenital probiotics. Clin Gastroenterol. 2004; 38(6 Suppl): S107-10.
9. Reid G, Beuerman D, Heinemann C, Bruce AW. Probiotic Lactobacillus dose required to restore and maintain a normal vaginal flora. FEMS Immunol Med Microbiol. 2001; 32(1): 37-41.
10. Ness RB, Hillier S, Richter HE, Soper DE, Stamm C, Bass DC, Sweet RL, Rice P. Can known risk factors explain racial differences in the occurrence of bacterial vaginosis? J Natl Med Assoc. 2003; 95(3): 201-12.
11. Reid G, Charbonneau D, Erb J, Kochanowski B, Beuerman D, Poehner R, Bruce AW. Oral use of Lactobacillus rhamnosus GR-1 and L. fermentum RC-14 significantly alters vaginal flora: randomized, placebo-controlled trial in 64 healthy women. FEMS Immunol Med Microbiol. 2003; 35(2): 131-4.
12. Solomon D, Davey D, Kurman R, Moriarty A, O'Connor D, Prey M, Raab S, Sherman M, David Wilbur D, Wright T, Jr, Young N. The 2001 Bethesda System Terminology for Reporting Results of Cervical Cytology. JAMA. 2002; 287: 2114-2119.
13. Broso PR, Buffetti G. The Papanicolaou classification in the Bethesda system; National Cancer Institute, Bethesda, Maryland. Minerva Ginecol. 1993; 45(11): 557-63.
14. Reid G, Jass J, Sebulsky MT, McCormick JK. Potential uses of probiotics in clinical practice. Clin Microbiol Rev. 2003; 16(4): 658-72.
15. Burton JP, Cadieux PA, Reid G. Improved understanding of the bacterial vaginal microbiota of women before and after probiotic instillation. Appl Environ Microbiol. 2003; 69(1): 97-101.
16. Reid, G. The extra intestinal effects of probiotics. In, Interventions for improving human health, Gibson GR (Ed), Wiley and Sons, Ltd., London, UK. 2005
17. Andreeva PM, Omar HA. Effectiveness of current therapy of bacterial vaginosis. Int J Adolesc Med Health. 2002; 14(2): 145-8.
18. Huang M, Wang JH. Gram stain as a relapse predictor of bacterial vaginosis after metronidazole treatment. J Microbiol Immunol Infect. 2005; 38(2): 137-40.
19. Paavonen J, Mangioni C, Martin MA, Wajszczuk CP. Vaginal clindamycin and oral metronidazole for bacterial vaginosis: a randomized trial. Obstet Gynecol. 2000; 96(2): 256-60.
20. Beigi RH, Austin MN, Meyn LA, Krohn MA, Hillier SL. Antimicrobial resistance associated with the treatment of bacterial vaginosis. Am J Obstet Gynecol. 2004; 191(4): 1124-9.
21. Cianci A, Giordano R, Delia A, Grasso E, Amodeo A, De Leo V, Caccamo F. Efficacy of Lactobacillus Rhamnosus GR-1 and of Lactobacillus Reuteri RC-14 in the treatment and prevention of vaginoses and bacterial vaginitis relapses. Minerva Ginecol. 2008; 60(5): 369-76.